Eli Lilly and Company (LLY) Dividend Yield: 0.57%
Is Eli Lilly and Company’s dividend yield high or low?
Eli Lilly and Company's dividend yield of 0.57% is 36% below its 5-year average of 0.89%, near the low end of its 5-year range (0.41%–1.53%).
As of Monday, June 15, 2026. 14.22% below its 12-month average of 0.66%.
Dividend Yield (0.57%) = TTM Dividends/Share ($6.46) / Share Price ($1133.00)
LLY Dividend Yield Chart
LLY Average Dividend Yield Chart
LLY Current vs Average Dividend Yield Chart
LLY Dividend Yield Metrics
DIVIDEND YIELD
0.57%
DIVIDEND YIELD AVG TTM
0.66%
DIVIDEND YIELD AVG 3Y
0.67%
DIVIDEND YIELD AVG 5Y
0.89%
DIVIDEND YIELD AVG 10Y
1.54%
DIVIDEND YIELD AVG 15Y
2.23%
DIVIDEND YIELD AVG 20Y
2.79%
CURRENT VS TTM AVG
-14.22%
CURRENT VS 3Y AVG
-15.18%
CURRENT VS 5Y AVG
-36.06%
CURRENT VS 10Y AVG
-63.04%
CURRENT VS 15Y AVG
-74.47%
CURRENT VS 20Y AVG
-79.57%
LLY Competitors' Dividend Yield
| NAME | MARKET CAP | DIVIDEND YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Eli Lilly and Company (LLY) | $1.07T | 0.57% | 0.66% | 0.67% | 0.89% |
| Johnson & Johnson (JNJ)vs › | $579.83B | 2.18% | 2.56% | 2.95% | 2.82% |
| AbbVie Inc. (ABBV)vs › | $402.35B | 2.96% | 3.10% | 3.50% | 3.71% |
| UnitedHealth Group Incorporated (UNH)vs › | $371.00B | 2.73% | 2.13% | 1.79% | 1.60% |
| Merck & Co., Inc. (MRK)vs › | $294.03B | 3.50% | 3.32% | 3.06% | 3.08% |
| AstraZeneca PLC (AZN)vs › | $277.22B | 1.79% | 1.83% | 2.02% | 2.13% |
| Amgen Inc. (AMGN)vs › | $191.70B | 2.76% | 2.97% | 3.09% | 3.16% |
| Thermo Fisher Scientific Inc. (TMO)vs › | $174.42B | 0.38% | 0.34% | 0.31% | 0.27% |
| Gilead Sciences, Inc. (GILD)vs › | $155.93B | 2.56% | 2.54% | 3.36% | 3.68% |
| Abbott Laboratories (ABT)vs › | $153.59B | 2.77% | 2.06% | 1.98% | 1.86% |
Eli Lilly and Company Dividend Yield Formula & Definition
Dividend yield is the trailing-12-month dividends per share divided by the share price — the cash income the stock pays at today's price. A yield far above a company's own history can signal either value or a market doubting the dividend; read it with the payout ratio.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Eli Lilly and Company Dividend Yield FAQ
- What is the dividend yield for Eli Lilly and Company (LLY)?
- The dividend yield for LLY stock is 0.57%.
- Is Eli Lilly and Company's dividend yield high or low?
- Eli Lilly and Company's dividend yield of 0.57% is 36% below its 5-year average of 0.89%, near the low end of its 5-year range (0.41%–1.53%).
- What is the TTM average dividend yield for Eli Lilly and Company (LLY)?
- The TTM average dividend yield for LLY stock is 0.66%.
- What is the 3Y average dividend yield for Eli Lilly and Company (LLY)?
- The 3Y average dividend yield for LLY stock is 0.67%.
- What is the 5Y average dividend yield for Eli Lilly and Company (LLY)?
- The 5Y average dividend yield for LLY stock is 0.89%.
- What is the 10Y average dividend yield for Eli Lilly and Company (LLY)?
- The 10Y average dividend yield for LLY stock is 1.54%.
- What is the 15Y average dividend yield for Eli Lilly and Company (LLY)?
- The 15Y average dividend yield for LLY stock is 2.23%.
- What is the 20Y average dividend yield for Eli Lilly and Company (LLY)?
- The 20Y average dividend yield for LLY stock is 2.79%.
Eli Lilly and Company Dividend Yield History
| DATE | DIVIDEND YIELD |
|---|---|
| 2026-06-12 | 0.57% |
| 2026-06-11 | 0.56% |
| 2026-06-09 | 0.56% |
| 2026-06-05 | 0.57% |
| 2026-06-03 | 0.60% |
| 2026-06-01 | 0.60% |
| 2026-05-28 | 0.57% |
| 2026-05-26 | 0.61% |
| 2026-05-21 | 0.62% |
| 2026-05-19 | 0.63% |
| 2026-05-15 | 0.79% |
| 2026-05-13 | 0.61% |
| 2026-05-11 | 0.64% |
| 2026-05-07 | 0.64% |
| 2026-05-05 | 0.63% |
| 2026-05-01 | 0.65% |
| 2026-04-29 | 0.73% |
| 2026-04-27 | 0.72% |
| 2026-04-23 | 0.68% |
| 2026-04-21 | 0.69% |
| 2026-04-17 | 0.67% |
| 2026-04-15 | 0.69% |
| 2026-04-13 | 0.67% |
| 2026-04-09 | 0.65% |
| 2026-04-07 | 0.67% |
| 2026-04-02 | 0.67% |
| 2026-03-31 | 0.68% |
| 2026-03-27 | 0.71% |
| 2026-03-25 | 0.68% |
| 2026-03-23 | 0.68% |
| 2026-03-19 | 0.68% |
| 2026-03-17 | 0.67% |
| 2026-03-13 | 0.63% |
| 2026-03-11 | 0.62% |
| 2026-03-09 | 0.62% |
| 2026-03-05 | 0.63% |
| 2026-03-03 | 0.62% |
| 2026-02-27 | 0.59% |
| 2026-02-25 | 0.61% |
| 2026-02-23 | 0.59% |
| 2026-02-19 | 0.61% |
| 2026-02-17 | 0.60% |
| 2026-02-12 | 0.58% |
| 2026-02-10 | 0.59% |
| 2026-02-06 | 0.57% |
| 2026-02-04 | 0.54% |
| 2026-02-02 | 0.57% |
| 2026-01-29 | 0.59% |
| 2026-01-27 | 0.58% |
| 2026-01-23 | 0.56% |
| 2026-01-21 | 0.56% |
| 2026-01-16 | 0.58% |
| 2026-01-14 | 0.56% |
| 2026-01-12 | 0.56% |
| 2026-01-08 | 0.55% |
| 2026-01-06 | 0.56% |
| 2026-01-02 | 0.56% |
| 2025-12-30 | 0.56% |
| 2025-12-26 | 0.56% |
| 2025-12-23 | 0.56% |
| 2025-12-19 | 0.56% |
| 2025-12-17 | 0.58% |
| 2025-12-15 | 0.56% |
| 2025-12-11 | 0.59% |
| 2025-12-09 | 0.61% |
| 2025-12-05 | 0.59% |
| 2025-12-03 | 0.58% |
| 2025-12-01 | 0.57% |
| 2025-11-26 | 0.54% |
| 2025-11-24 | 0.56% |
| 2025-11-20 | 0.58% |
| 2025-11-18 | 0.58% |
| 2025-11-14 | 0.71% |
| 2025-11-12 | 0.57% |
| 2025-11-10 | 0.60% |
| 2025-11-06 | 0.62% |
| 2025-11-04 | 0.64% |
| 2025-10-31 | 0.67% |
| 2025-10-29 | 0.71% |
| 2025-10-27 | 0.70% |
| 2025-10-23 | 0.71% |
| 2025-10-21 | 0.73% |
| 2025-10-17 | 0.72% |
| 2025-10-15 | 0.70% |
| 2025-10-13 | 0.71% |
| 2025-10-09 | 0.68% |
| 2025-10-07 | 0.69% |
| 2025-10-03 | 0.69% |
| 2025-10-01 | 0.70% |
| 2025-09-29 | 0.80% |
| 2025-09-25 | 0.81% |
| 2025-09-23 | 0.78% |
| 2025-09-19 | 0.77% |
| 2025-09-17 | 0.76% |
| 2025-09-15 | 0.78% |
| 2025-09-11 | 0.77% |
| 2025-09-09 | 0.77% |
| 2025-09-05 | 0.80% |
| 2025-09-03 | 0.79% |
| 2025-08-29 | 0.79% |
| 2025-08-27 | 0.79% |
| 2025-08-25 | 0.83% |
| 2025-08-21 | 0.82% |
| 2025-08-19 | 0.82% |
| 2025-08-15 | 0.83% |
| 2025-08-13 | 0.85% |
| 2025-08-11 | 0.88% |
| 2025-08-07 | 0.87% |
| 2025-08-05 | 0.73% |
| 2025-08-01 | 0.73% |
| 2025-07-30 | 0.74% |
| 2025-07-28 | 0.69% |
| 2025-07-24 | 0.70% |
| 2025-07-22 | 0.72% |
| 2025-07-18 | 0.73% |
| 2025-07-16 | 0.71% |
| 2025-07-14 | 0.70% |
| 2025-07-10 | 0.71% |
| 2025-07-08 | 0.72% |
| 2025-07-03 | 0.72% |
| 2025-07-01 | 0.72% |
| 2025-06-27 | 0.72% |
| 2025-06-25 | 0.71% |
| 2025-06-23 | 0.73% |
| 2025-06-18 | 0.71% |
| 2025-06-16 | 0.69% |
| 2025-06-12 | 0.69% |
| 2025-06-10 | 0.69% |
| 2025-06-06 | 0.73% |
| 2025-06-04 | 0.73% |
| 2025-06-02 | 0.75% |
| 2025-05-29 | 0.78% |
| 2025-05-27 | 0.77% |
| 2025-05-22 | 0.78% |
| 2025-05-20 | 0.75% |
| 2025-05-16 | 0.74% |
| 2025-05-14 | 0.75% |
| 2025-05-12 | 0.71% |
| 2025-05-08 | 0.72% |
| 2025-05-06 | 0.70% |
| 2025-05-02 | 0.66% |
| 2025-04-30 | 0.60% |
| 2025-04-28 | 0.62% |
| 2025-04-24 | 0.63% |
| 2025-04-22 | 0.65% |
| 2025-04-17 | 0.64% |
| 2025-04-15 | 0.71% |
| 2025-04-11 | 0.74% |
| 2025-04-09 | 0.72% |
| 2025-04-07 | 0.75% |
| 2025-04-03 | 0.68% |
| 2025-04-01 | 0.67% |
| 2025-03-28 | 0.66% |
| 2025-03-26 | 0.65% |
| 2025-03-24 | 0.62% |
| 2025-03-20 | 0.64% |
| 2025-03-18 | 0.66% |
| 2025-03-14 | 0.66% |
| 2025-03-12 | 0.66% |
| 2025-03-10 | 0.65% |
| 2025-03-06 | 0.59% |
| 2025-03-04 | 0.59% |
| 2025-02-28 | 0.59% |
| 2025-02-26 | 0.59% |
| 2025-02-24 | 0.61% |
| 2025-02-20 | 0.62% |
| 2025-02-18 | 0.63% |
| 2025-02-13 | 0.45% |
| 2025-02-11 | 0.60% |
| 2025-02-07 | 0.59% |
| 2025-02-05 | 0.62% |
| 2025-02-03 | 0.64% |
| 2025-01-30 | 0.63% |
| 2025-01-28 | 0.65% |
| 2025-01-24 | 0.66% |
| 2025-01-22 | 0.69% |
| 2025-01-17 | 0.72% |
| 2025-01-15 | 0.70% |
| 2025-01-13 | 0.65% |
| 2025-01-08 | 0.66% |
| 2025-01-06 | 0.68% |
| 2025-01-02 | 0.67% |
| 2024-12-30 | 0.67% |
| 2024-12-26 | 0.65% |
| 2024-12-23 | 0.65% |
| 2024-12-19 | 0.69% |
| 2024-12-17 | 0.67% |
| 2024-12-13 | 0.66% |
| 2024-12-11 | 0.65% |
| 2024-12-09 | 0.65% |
| 2024-12-05 | 0.63% |
| 2024-12-03 | 0.64% |
| 2024-11-29 | 0.65% |
| 2024-11-26 | 0.66% |
| 2024-11-22 | 0.70% |
| 2024-11-20 | 0.69% |
| 2024-11-18 | 0.72% |
| 2024-11-14 | 0.50% |
| 2024-11-12 | 0.61% |
| 2024-11-08 | 0.60% |
| 2024-11-06 | 0.65% |
| 2024-11-04 | 0.62% |
| 2024-10-31 | 0.61% |
| 2024-10-29 | 0.56% |
| 2024-10-25 | 0.56% |
| 2024-10-23 | 0.56% |
| 2024-10-21 | 0.56% |
| 2024-10-17 | 0.55% |
| 2024-10-15 | 0.55% |
| 2024-10-11 | 0.54% |
| 2024-10-09 | 0.55% |
| 2024-10-07 | 0.56% |
| 2024-10-03 | 0.57% |
| 2024-10-01 | 0.57% |
| 2024-09-27 | 0.57% |
| 2024-09-25 | 0.54% |
| 2024-09-23 | 0.55% |
| 2024-09-19 | 0.55% |
| 2024-09-17 | 0.56% |
| 2024-09-13 | 0.54% |
| 2024-09-11 | 0.55% |
| 2024-09-09 | 0.55% |
| 2024-09-05 | 0.55% |
| 2024-09-03 | 0.53% |
| 2024-08-29 | 0.53% |
| 2024-08-27 | 0.53% |
| 2024-08-23 | 0.53% |
| 2024-08-21 | 0.53% |
| 2024-08-19 | 0.55% |
| 2024-08-15 | 0.54% |
| 2024-08-13 | 0.41% |
| 2024-08-09 | 0.55% |
| 2024-08-07 | 0.63% |
| 2024-08-05 | 0.63% |
| 2024-08-01 | 0.58% |
| 2024-07-30 | 0.62% |
| 2024-07-26 | 0.60% |
| 2024-07-24 | 0.57% |
| 2024-07-22 | 0.56% |
| 2024-07-18 | 0.57% |
| 2024-07-16 | 0.52% |
| 2024-07-12 | 0.51% |
| 2024-07-10 | 0.52% |
| 2024-07-08 | 0.53% |
| 2024-07-03 | 0.54% |
| 2024-07-01 | 0.53% |
| 2024-06-27 | 0.53% |
| 2024-06-25 | 0.54% |
| 2024-06-21 | 0.55% |
| 2024-06-18 | 0.55% |
| 2024-06-14 | 0.55% |
| 2024-06-12 | 0.56% |
| 2024-06-10 | 0.56% |
| 2024-06-06 | 0.58% |
| 2024-06-04 | 0.58% |
| 2024-05-31 | 0.59% |
| 2024-05-29 | 0.60% |
| 2024-05-24 | 0.60% |
| 2024-05-22 | 0.61% |
| 2024-05-20 | 0.62% |
Showing the most recent 260 of 3,774 data points. The chart above shows the full history.
About Eli Lilly and Company
Eli Lilly and Company is a prominent global pharmaceutical firm dedicated to the research, development, and commercialization of human medicines across the world. Its therapeutic offerings include a comprehensive suite of diabetes medications. This encompasses various insulin formulations like Basaglar, the Humalog family (e.g., Mix 75/25, U-100, U-200, Mix 50/50), insulin lispro products (including protamine and mix 75/25), and the Humulin line (e.g., 70/30, N, R, U-500). Furthermore, Eli Lilly provides specialized treatments for type 2 diabetes, such as Jardiance, Trajenta, and Trulicity. In oncology, Eli Lilly offers a robust portfolio targeting various cancers. These include Alimta for non-small cell lung cancer (NSCLC) and malignant pleural mesothelioma; Cyramza, indicated for metastatic gastric cancer, gastro-esophageal junction adenocarcinoma, metastatic NSCLC, metastatic colorectal cancer, and hepatocellular carcinoma; Erbitux for colorectal and various head and neck cancers; Retevmo, used in metastatic NSCLC, medullary thyroid, and other thyroid cancers; Tyvyt for relapsed or refractory classic Hodgkin's lymphoma and non-squamous NSCLC; and Verzenio, prescribed for HR+, HER2- metastatic breast cancer, node-positive, and early breast cancer. For autoimmune and inflammatory conditions, the company markets Olumiant for rheumatoid arthritis, and Taltz, which addresses plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondyloarthritis. Addressing neurological and pain management needs, Eli Lilly provides Cymbalta for depressive disorder, diabetic peripheral neuropathic pain, generalized anxiety disorder, fibromyalgia, and chronic musculoskeletal pain. Emgality is available for migraine prevention and episodic cluster headaches, while Zyprexa treats schizophrenia, bipolar I disorder, and aids in bipolar maintenance. Other significant products include Bamlanivimab and etesevimab, along with Bebtelovimab, both developed for COVID-19. Cialis is offered for erectile dysfunction and benign prostatic hyperplasia, and Forteo is available for osteoporosis. Eli Lilly actively engages in strategic collaborations with numerous partners, including Incyte Corporation; Boehringer Ingelheim Pharmaceuticals, Inc.; AbCellera Biologics Inc.; Junshi Biosciences; Regor Therapeutics Group; Lycia Therapeutics, Inc.; Kumquat Biosciences Inc.; Entos Pharmaceuticals Inc.; and Foghorn Therapeutics Inc. Established in 1876, Eli Lilly and Company maintains its corporate headquarters in Indianapolis, Indiana.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- CEO
- David A. Ricks